Ann: Imugene to Present at Annual JPMorgan Healthcare Conference, page-70

Whilst much focus is being given to the trials results from the MAST trial this slide here is what is exciting me.  You can never underestimate how much weight having a home grown team appeals to Yanks.  This slide will impress them no end.  Just look at the range of cutting edge companies are include on IMU’s collective resume.   This alone should quell any fears shareholders have about doing a deal at some stage.. All of these IMU team can stroll through JPM networking with old contacts and making new friends. Yanks love networking at these conferences. They jump at every opportunity to make meaningful introductions.  I hope all of them are in attendance.  This is where it all happens.  Without sounding ambivalent about the science it’s hard to get past the quality of this team and the credibility they bring to IMU.  And I’ll take the opportunity to congratulate Paul Hopper for creating this outstanding company.